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Candace N. Rouchon,* Anhphan T. Ly, John P. Noto, Feng Luo,* Sergio Lizano,*
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ABSTRACT Group A streptococci (GAS) are highly prevalent human pathogens
whose primary ecological niche is the superﬁcial epithelial layers of the throat
and/or skin. Many GAS strains with a strong tendency to cause pharyngitis are distinct from strains that tend to cause impetigo; thus, genetic differences between
them may confer host tissue-speciﬁc virulence. In this study, the FbaA surface protein gene was found to be present in most skin specialist strains but largely absent
from a genetically related subset of pharyngitis isolates. In an ΔfbaA mutant constructed in the impetigo strain Alab49, loss of FbaA resulted in a slight but signiﬁcant decrease in GAS ﬁtness in a humanized mouse model of impetigo; the ΔfbaA
mutant also exhibited decreased survival in whole human blood due to phagocytosis. In assays with highly sensitive outcome measures, Alab49ΔfbaA was compared
to other isogenic mutants lacking virulence genes known to be disproportionately
associated with classical skin strains. FbaA and PAM (i.e., the M53 protein) had additive effects in promoting GAS survival in whole blood. The pilus adhesin tip protein
Cpa promoted Alab49 survival in whole blood and appears to fully account for the
antiphagocytic effect attributable to pili. The ﬁnding that numerous skin strainassociated virulence factors make slight but signiﬁcant contributions to virulence underscores the incremental contributions to ﬁtness of individual surface protein genes
and the multifactorial nature of GAS-host interactions.
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G

roup A streptococcus (GAS; Streptococcus pyogenes) is a global human pathogen
that causes ⬃750 million infections per year (1, 2). The epithelia of the throat and
skin are the primary ecological niches and reservoirs for GAS. It is well established that
some GAS strains have a strong predilection for causing infection only at the throat
(pharyngitis), whereas other strains have a high tendency to cause superﬁcial infection
only at the skin (impetigo). The determinants of tissue site preference for GAS infection
and their relative contributions to ﬁtness and virulence are not fully understood.
The key sources of structural and functional diversity of GAS exoproteins include the
genes within the emm and FCT regions, which map on the chromosome approximately
equidistant from the origin of replication, but on opposite sides. Several statistically
signiﬁcant associations between emm region genes (encoding M protein and other
surface and secreted proteins), FCT region genes (encoding surface pili and other
adhesins), and clinical associations with impetigo versus pharyngitis have been made
(reviewed in reference 3). Although there are ⬎200 emm types, the content and
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TABLE 1 Distribution of fbaA among genotype-deﬁned subpopulations of GAS
Clustera
I and II combined
I
II
I

II

No. of
isolates
85d
41
44
10
29
2
3
3
38
17
33
43

No. of fbaApositive isolatesb
73
31
42
2
28
1
1
3
38
4
32
42

No. of fbaAnegative isolates
12
10
2
8
1
1
2
0
0
13
1
1

% fbaA-positive
isolatese
85.9
75.6
95.5
20.0
96.6
NA
NA
NA
100
23.5
97.0
97.7

Comparator group

P valuec

Cluster II, all

0.012

Cluster I, pattern D

⬍0.0001

Cluster I/II, pattern D
Cluster I/II, pattern E
Cluster I/II, pattern A-C

⬍0.0001
NS
⬍0.0001

aAssignment

is based on accessory gene haplotypes, as described previously (13).
by PCR ampliﬁcation of genomic DNA.
cBy Fisher’s exact test (two-tailed). NS, not signiﬁcant.
dAll 85 GAS isolates harbor distinct emm types.
eNA, not applicable.
bDetermined

arrangement of emm and emm-like genes can be organized into the following three
emm pattern groupings that closely correspond to the primary tissue site of infection:
throat specialists (emm patterns A to C [emm pattern A-C]), skin specialists (emm
pattern D), and generalists (emm pattern E). The specialized plasminogen-binding M
protein (PAM) is exclusive to the emm pattern D skin specialists, as is a lineage of the
plasminogen activator streptokinase, which is encoded by the ska locus that lies within
the greater emm region (4, 5). Throat and skin specialist strains also display signiﬁcant
differences in the content of FCT region genes (6). The contributions of several
impetigo-associated genes to virulence have been validated experimentally (7–12).
In this report, the relationship between the less-well-studied GAS surface protein
gene fbaA and skin versus throat specialist strains is deﬁned, and the effect of FbaA on
the virulence of an impetigo strain is quantiﬁed. The impact of FbaA on GAS pathogenesis is compared to those of two other cell surface protein genes that are disproportionately associated with classical skin strains.
RESULTS
Distribution of fbaA in the GAS population. Since fbaA is an accessory gene as
opposed to a core gene, its relative distribution among GAS strains may reveal
biologically important associations that, in turn, may provide clues to the role of FbaA
in GAS disease. For a genetically diverse set of 85 GAS strains representing 85 distinct
emm types, the data show that the majority (86%) harbor fbaA (Table 1). GAS strains
lacking fbaA are concentrated in the cluster I group (10 of 12 [83%] fbaA-negative
strains) (Table 1). Cluster I is one of two major groupings of genetically distinct GAS
strains, deﬁned by the presence versus absence of numerous accessory gene loci (13).
Furthermore, cluster I strains are almost exclusively of emm pattern A-C or emm pattern
D (i.e., throat or skin specialists, respectively), whereby the vast majority of emm pattern
D strains belong to cluster I, as does a clinically important subset of emm pattern A-C
strains (13). Strikingly, 80% of cluster I emm pattern A-C strains are fbaA deﬁcient, in
contrast to ⬍4% of cluster I pattern D strains (P ⬍ 0.0001; Fisher’s exact test) (Table 1).
The fbaA chromosomal regions of a classical skin strain (Alab49) (emm53; emm pattern
D) and a throat strain (emm6; emm pattern A-C), both of which are assigned to the
cluster I grouping, are illustrated in Fig. 1B.
To better assess clinical relevance, a sample of 77 GAS isolates recovered from
known cases of pharyngitis or impetigo and having emm types represented by the GAS
strains belonging to the cluster I group (13) was analyzed for the presence or absence
of fbaA. This collection is a “convenience” sample selected from in-house GAS strains;
together, the 77 organisms exhibit high genetic diversity, representing 28 of the 41
emm types assigned to cluster I. Strikingly, the data show that only 20% of the cluster
November 2017 Volume 85 Issue 11 e00374-17
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emm pattern
group
All
All
All
A-C
D
E
A-C
D
E
A-C
D
E
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FIG 1 Distribution of fbaA among cluster I pharyngitis and impetigo isolates. (A) fbaA-negative (open)
and fbaA-positive (ﬁlled) isolates. **, P ⬍ 0.01 (Fisher’s exact test, two-tailed). (B) Chromosomal maps of
fbaA and ﬂanking genes for representative impetigo (Alab49; emm53, emm pattern D, clade Y, cluster I,
fbaA positive) and pharyngitis (MGAS10394; emm6, emm pattern A-C, clade Y, cluster I, fbaA negative)
isolates. Genes and intergenic regions are not drawn to scale (13, 39).

I pharyngitis isolates harbor fbaA, compared to 100% of the impetigo isolates, a
distinction that has high statistical signiﬁcance (Fig. 1A, left panel). Thus, an important
subset of pharyngitis isolates which are otherwise highly similar to classical emm
pattern D impetigo strains in their content of accessory genes (13) can be distinguished
from those skin strains by a relative lack of fbaA.
emm type assignments can be stratiﬁed further according to emm phylogenetic
clade (X or Y), which is based on amino acid sequence alignment of the entire
surface-exposed portion of the M protein (14). The majority (78%) of GAS isolates in the
set of 77 cluster I GAS isolates harbor clade Y emm types. Unlike clade Y impetigo
isolates, nearly all clade Y pharyngitis isolates (89%) lack fbaA (Fig. 1A, right panel).
Included among the pharyngitis isolates lacking fbaA are the highly prevalent clade Y
emm types 3, 5, 6, and 18 (data not shown), which rank high among the emm types
most often recovered in association with acute rheumatic fever (15). Taken together,
the ﬁndings on the distribution of fbaA within the GAS population provided the basis
for a testable hypothesis, i.e., that FbaA is a critical virulence factor for superﬁcial GAS
infection at the skin.
Bacterial cell surface expression of FbaA. Immunoﬂuorescence assay of whole
bacterial cells was used to evaluate the expression of FbaA on the cell surface of the
cluster I classical skin strain Alab49 (emm53; clade Y, emm pattern D). The data show
that FbaA was expressed in a growth phase-dependent manner, whereupon FbaA was
present during logarithmic growth but absent in stationary phase (Table 2; see Fig. S4B
and C in the supplemental material). Loss of surface FbaA during stationary phase can
be explained by its degradation via the secreted cysteine protease SpeB, as evidenced
by the recovery of FbaA cell surface expression following bacterial growth in the
presence of the cysteine protease inhibitor E64 (Fig. S4D) and the presence of FbaA on
the surface of the Alab49ΔspeB isogenic mutant (Fig. S4H).
In strain Alab49, transcription of fbaA was activated by the global transcriptional
regulator Mga, whereby the activation effect was ⬃4-fold greater during logarithmicNovember 2017 Volume 85 Issue 11 e00374-17
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TABLE 2 Summary of immunoﬂuorescence staining of whole bacterial cells
Alab49
construct
WT

a0,

E64 cysteine protease
inhibitor
Absent
Absent
Absent
Present

Antiserum
Preimmune
Anti-rFbaA
Anti-rFbaA
Anti-rFbaA

Immunoﬂuorescence
staining scorea
0
3⫹
0
3⫹

Stationary
Stationary
Stationary
Stationary

Present
Present
Present
Absent

Anti-rFbaA
Anti-rFbaA
Anti-rFbaA
Anti-rFbaA

0
0
0
3⫹

Downloaded from http://iai.asm.org/ on July 5, 2018 by NEW YORK MEDICAL COLLEGE

ΔfbaA
ΔfbaAΔpam
Δmga
ΔspeB

Growth phase
Logarithmic
Logarithmic
Stationary
Stationary

no staining; 3⫹, strong staining.

phase growth than during stationary phase (Table 3), conﬁrming previous ﬁndings (9).
As expected, cell surface expression of FbaA in strain Alab49 was also dependent on
Mga, as evidenced by the lack of detectable FbaA on Alab49Δmga following its growth
in E64 (Fig. S4G). As a control, loss of Mga was shown to have no measurable effect on
the SpeB activity phenotype during cultivation on Columbia agar (Table S3).
Two mutant constructs with inactivated fbaA genes were characterized for cell
surface expression of FbaA. As expected, FbaA was absent from the cell surface of
Alab49ΔfbaA and Alab49ΔfbaAΔpam mutants following their growth in E64-containing
culture medium (Fig. S4E and F). Importantly, the ΔfbaA mutants showed no evidence
of transcriptional polar effects on transcription of an upstream (scpA) or downstream
(lmb) gene (Table 3).
Contributions of fbaA and pam to impetigo. The wild-type Alab49 strain
(Alab49WT) was directly compared to its ΔfbaA isogenic mutant for relative ﬁtness and
virulence in a humanized experimental model of impetigo. In each test experiment,
bacteria grown to mid-logarithmic phase were inoculated onto two grafts of a single
hu-skin-SCID mouse (SCID mouse engrafted with human skin), whereby each graft
received ⬃2,200 CFU; this inoculum size is likely a close parallel to the infective dose
encountered during natural human infections. The data show that, by 6 days, there was
a mean average of 12.295 population doublings for Alab49WT, compared to 10.988
population doublings for the Alab49ΔfbaA mutant; the difference in the relative
change in CFU between the two organisms is statistically signiﬁcant (Fig. 2) (t ⫽ 0.035;
two-tailed paired t test). The data correspond to a relative growth index for the ΔfbaA
mutant that is only 39% of that of Alab49WT (Table 4). Although FbaA makes a
statistically signiﬁcant contribution to GAS ﬁtness and virulence at the skin, its overall
effect is rather modest, and Alab49 is still able to thrive in the absence of FbaA.
Previous studies showed that loss of either pam (12) or mga (9) results in a
signiﬁcant loss of virulence at the skin for GAS strain Alab49. Mga is a positive regulator
of pam and fbaA transcription in Alab49 (Table 3) (9). The plasminogen-binding M
protein (PAM) is disproportionately associated with the emm pattern D skin specialist
strains (4). In this study, the Alab49Δmga mutant was directly compared to an
Alab49ΔfbaAΔpam double mutant for virulence in the hu-skin-SCID mouse model of
impetigo. The data show a mean average of only 3.433 population doublings for the
Δmga mutant, compared to 10.558 population doublings for the ΔfbaAΔpam double

TABLE 3 Effects of genetic deletions on RNA transcript levels of fbaA and ﬂanking genes
Alab49
construct
ΔfbaA
ΔfbaAΔpam
Δmga
aOD

600
bBased

RNA transcript level relative to that in Alab49WTb
Growth phasea
Logarithmic
Logarithmic
Logarithmic
Stationary

pam
ND
ND
0.012 ⫾ 0.011
0.096 ⫾ 0.134

scpA
1.59 ⫾ 0.076
1.22 ⫾ 1.06
0.045 ⫾ 0.049
ND

fbaA
⬍0.001
⬍0.001
0.043 ⫾ 0.027
0.164 ⫾ 0.171

lmb
1.12 ⫾ 0.84
0.78 ⫾ 0.43
ND
ND

values for logarithmic cultures ranged from 0.448 to 0.482.
on two or more independent RNA preparations analyzed by qRT-PCR. ND, not determined.
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FIG 2 Bacterial population doubling in an experimental model of impetigo. Pairs of human skin grafts on
doubly engrafted hu-skin-SCID mice (n ⫽ 5 animals per group) were infected with either Alab49WT (;
mean average inoculum, 2,266 ⫾ 321 CFU) and Alab49ΔfbaA (; inoculum, 2,109 ⫾ 628 CFU) or the
ΔfbaAΔpam (Œ; inoculum, 1,258 ⫾ 160 CFU) and Δmga (; inoculum 1,255 ⫾ 422 CFU) mutants. Paired
t test (two-tailed) values for differences in bacterial population doubling are shown as follows: *, t ⱕ 0.05;
and **, t ⬍ 0.01. Differences in inoculum doses were not statistically signiﬁcant between graft inoculum
pairs (paired t test) (data not shown).

mutant; the difference in net reproductive growth at the skin between these two
genetic constructs is highly signiﬁcant (Fig. 2) (t ⫽ 0.0014; two-tailed paired t test).
Mean average inoculum doses were slightly lower (⬃1,250 CFU) than those used for the
group of mice infected with both Alab49WT and the ΔfbaA mutant.
For experiments in which Alab49 constructs were used to infect different sets of
mice, each graft could be treated as an independent experiment, and the unpaired t
test was used for statistical analysis. The data show that the differences in CFU between
Alab49Δmga and either Alab49WT or Alab49ΔfbaA at 6 days postinoculation were
highly signiﬁcant (Fig. 2) (t ⫽ 0.0010 and 0.0019, respectively; two-tailed unpaired t test
with Welch’s correction for unequal variance). In contrast, population doubling at the
skin for the Alab49ΔfbaAΔpam construct was not signiﬁcantly different from that for
either the ΔfbaA mutant or Alab49WT. In fact, the increases in population size for
Alab49ΔfbaA and Alab49ΔfbaAΔpam were virtually identical for the two groups of mice
(10.998 and 10.558 population doublings, respectively). On applying the unpaired t test
to Alab49WT versus the ΔfbaA mutant, the difference in population doubling was not
statistically signiﬁcant (t ⫽ 0.0819).
In summary, signiﬁcant differences between the Alab49ΔfbaA single-gene mutant
and the Alab49ΔfbaAΔpam double-gene mutant were not evident in terms of bacterial
growth at the superﬁcial layers of the skin at 6 days postinoculation. Furthermore, only
modest (but statistically signiﬁcant by the paired t test) differences were detected
between Alab49WT and Alab49ΔfbaA. The ﬁndings point to a critical role for additional,
unidentiﬁed Mga-regulated genes in ﬁtness and infectivity at the skin.

TABLE 4 Relative growth indices of Alab49 and Mga regulon mutants under different experimental conditions
Relative growth index
Test organism
ΔfbaA
Δpam
ΔfbaAΔpam

Comparator organism
WT
WT
WT

Human skin graft on SCID
mouse (6 days)a
0.394
NDb
0.462

Rotation in whole
human blood (3 h)
0.464
0.215
0.107

Rotation in human
plasma (3 h)
1.146
1.065
0.929

Δmga

WT
ΔfbaAΔpam

0.005
0.012

0.028
0.123

1.068
NDb

aThe

correlation coefﬁcient between bacterial growth indices for infected skin grafts and those for rotation in whole blood (excluding the Δpam construct) is
nonsigniﬁcant (Pearson r ⫽ 0.5390).
bND, not determined.
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FIG 3 Bacterial population doubling in whole blood. Pairs of Alab49WT and/or isogenic mutant strains were
rotated in whole human blood for 3 h (bactericidal assay), and the increase in bacterial population size
relative to the inoculum size was measured. The mean average value for the log2 increase in CFU is
indicated for each sample group (bar); a net loss of CFU was given a score of zero. Paired t test (two-tailed)
values for differences in the number of bacterial population doublings are shown as follows: **, t ⬍ 0.01.
Differences in inoculum doses were not statistically signiﬁcant between bacterial pairs (two-tailed paired t
test) (data not shown); each set of comparisons (A to F) employed 2 to 4 different blood donors. The
difference between groups in panel F (ΔfbaA versus ΔfbaAΔpam) is also highly signiﬁcant (two-tailed paired
t test); however, the sample size is smaller than the minimum (i.e., 5 pairs) that is recommended for
implementing this statistical test.

Roles of fbaA and pam in bacterial survival and growth in human blood. The
hu-skin-SCID mouse model measures a complex series of host-pathogen interplays
during infection, including GAS interactions with extravasated mouse neutrophils at the
epidermis (11, 16, 17). The Lanceﬁeld bactericidal assay was used to measure the
resistance of Alab49WT and its isogenic mutants to killing via opsonophagocytosis in
whole human blood. Experiments comparing Alab49WT to the ΔfbaA isogenic mutant
indicated that the contribution of FbaA to the antiphagocytic effect was highly significant (Fig. 3A), whereby the number of population doublings averaged 6.073 and 7.156
for Alab49ΔfbaA and the WT, respectively (t ⬍ 0.01; two-tailed paired t test). Over the
3-h period, the growth index of the Alab49ΔfbaA mutant was 46.4% of the value for the
WT (Table 4), indicating that even without FbaA, Alab49 can undergo substantial
reproductive growth in whole blood, albeit with a reduction in relative ﬁtness.
Compared to FbaA, PAM (M53 protein) had an even more marked effect on
resistance to opsonophagocytosis (Fig. 3B), whereby the Alab49Δpam construct exhibited a growth index that was 21.5% of the value for the WT over the 3-h assay (Table
4). Compared to the single-gene mutants, the double-gene mutant Alab49ΔfbaAΔpam
was even more susceptible to opsonophagocytosis (Fig. 3C), with a growth index that
was 10.7% of that of Alab49WT (Table 4). The hypothesis that PAM and FbaA most likely
have additive effects is supported by their relative growth index values: the product of
0.464 (for the ΔfbaA mutant relative to the WT) and 0.215 (for the Δpam mutant relative
to the WT) equates to 0.100 (predicted), close to the actual value of 0.107 (Table 4).
The mean average number of population doublings in whole human blood was
5.222 for the Alab49Δpam construct and 3.958 for the Alab49ΔfbaAΔpam construct
(Fig. 3B and C). The population doubling values equate to net population doubling times
November 2017 Volume 85 Issue 11 e00374-17
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of 29.6, 34.5, and 45.5 min for Alab49ΔfbaA, Alab49Δpam, and Alab49ΔfbaAΔpam, respectively, over the 3 h of incubation (Fig. 3A to C); in contrast, the population doubling
times of the comparator strain Alab49WT were shorter, ranging from 23.7 to 25.1 min.
As an experimental control to rule out intrinsic growth defects, Alab49WT and each
isogenic mutant were rotated in human plasma for 3 h; the data show that all
constructs displayed nearly equivalent growth (Table S3). In summary, the antiphagocytic effects of FbaA and PAM contribute to the ﬁtness of impetigo strain Alab49 during
rotation in whole human blood.
Bactericidal assays testing the Alab49Δmga mutant showed a very large loss in the
mean average number of population doublings (Fig. 3D). The substantially lower
growth index value for the Δmga construct than that for the Alab49ΔfbaAΔpam double
mutant (Fig. 3E; Table 4) indicates that other Mga-regulated genes, in addition to the
FbaA and PAM genes, make a signiﬁcant contribution to the antiphagocytic phenotype
of Alab49. Transcriptomics reveals that Mga can either activate or repress the transcription of ⬎10% of genes in a given GAS strain (18). Relative to Alab49WT,
Alab49Δmga displayed decreased transcription of several genes mapping to the emm
region (mrp, pam, enn, scpA, and fbaA), as demonstrated by quantitative reverse
transcription-PCR (qRT-PCR) (Table 3; Table S4). Transcomplemention of the Δmga
mutant with a plasmid harboring mga plus its upstream promoter region (Δmga::
pMga667) led to an approximate restoration of WT levels of RNA transcripts for the
surface protein genes tested (Table S4).
In summary, loss of FbaA reduced Alab49 survival in whole blood ⬃2-fold, whereas
loss of PAM reduced Alab49 survival ⬃5-fold, based on relative growth indices. The
concurrent loss of FbaA and PAM reduced Alab49 survival ⬃10-fold (Fig. 3; Table 4).
Loss of Mga reduced Alab49 survival ⬃35-fold, which is indicative of a role for
additional, unidentiﬁed Mga-regulated genes conferring a net effect of resistance to
opsonophagocytosis. These ﬁndings roughly follow the trend for population doubling
on infected human skin grafts, which undergo extensive inﬁltration by mouse neutrophils; however, the correlation between relative growth indices for the two different
experimental models, with four pairwise comparisons (Table 4), is not statistically
signiﬁcant.
Role of FCT region genes in bacterial growth in human blood. Isogenic mutants
with defects in pilus formation were previously shown to exhibit highly signiﬁcant
losses in growth and virulence in the hu-skin-SCID mouse model of impetigo compared
to the growth and virulence of Alab49WT following inoculation of logarithmic-phase
cultures (7, 8). The gene encoding the (purported) pilus tip adhesin Cpa is disproportionately associated with emm pattern D skin specialist strains compared to emm
pattern A-C throat specialist strains (6). Thus, it was of interest to determine whether
the loss in virulence during skin infection by FCT region mutants correlated with a
diminished antiphagocytic effect in whole blood.
Deletion of the nra gene (Alab49Δnra), which encodes a transcriptional activator of
pilus gene expression in strain Alab49, resulted in a statistically signiﬁcant reduction
of bacterial growth in human blood (Fig. 4A; Table 5). The loss in bacterial survival was
of a similar magnitude for the Alab49ΔnraIG isogenic mutant (Fig. 4B and C), which
lacks both nra and the nra-cpa intergenic region (10), which contains promoter sites for
transcription of both genes (Fig. S3). Deletion of the gene encoding the (putative) pilus
adhesin protein Cpa (Alab49Δcpa mutant) also resulted in a highly signiﬁcant decrease
in survival in the bactericidal assay (Fig. 4D). Overall, both the Nra and Cpa effects were
somewhat modest, with growth indices that were ⬃65% that of Alab49WT (Table 5).
Thus, mutagenesis of either nra or cpa leaves most of the bacterium’s antiphagocytic
properties intact. Direct comparison of the Alab49Δnra and Alab49ΔnraIG mutants to
the Alab49Δcpa mutant (Fig. 4E) revealed no apparent difference in bacterial growth,
providing strong support that Cpa alone accounts for (nearly) all of the antiphagocytic
effect conferred by Nra-regulated genes (8). The observed reduction in the antiphagocytic effect (Fig. 4A to D) may provide a (partial) explanation for the reduced virulence
iai.asm.org 7
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FIG 4 Bacterial population doubling in whole blood for FCT region mutants. Pairs of Alab49WT and/or
isogenic mutant strains were rotated in whole human blood for 3 h (bactericidal assay), and the increase
in bacterial population size relative to the inoculum size was measured. The mean average value for the
log2 increase in CFU is indicated for each sample group (bar). Paired t test (two-tailed) values for differences
in the number of bacterial population doublings are shown as follows: *, t ⬍ 0.05; **, t ⬍ 0.01; and N.S., not
signiﬁcant. Differences in inoculum doses were not statistically signiﬁcant between bacterial pairs (twotailed paired t test) (data not shown); each set of comparisons (A to F) employed 2 to 4 different blood
donors.

of Alab49Δnra and Alab49Δcpa mutants in the humanized mouse model of impetigo
(7, 8).
MsmR is a second transcriptional regulator encoded within the FCT region of Alab49.
In this GAS strain, MsmR acts as both an activator of the (putative) ﬁbronectin
(Fn)-binding protein gene prtF2 and a repressor of nra (and cpa) transcription (8, 10),
and it possibly affects the transcription of numerous other genes as well (19). Compared directly to Alab49WT, the isogenic Alab49ΔmsmR mutant exhibited a statistically
signiﬁcant increase in population doubling (Fig. 4F; Table 5), consistent with the idea
that increased pilus expression by Alab49ΔmsmR may lead to a higher survival rate in
whole blood. Overall, the effect of cpa loss on the antiphagocytic effect (⬃1.6-fold
reduction in growth index) (Table 5) was slightly less than that observed for loss of fbaA
(⬃2.2-fold reduction) (Table 4).

TABLE 5 Relative growth indices of Alab49 and FCT region mutants in the bactericidal
assay
Relative growth index
Test organism
Δnra
ΔnraIG
Δnra ⫹ ΔnraIG combined
Δcpa
ΔmsmR
Δnra ⫹ ΔnraIG combined
aSee

Comparator
organism
WT
WT
WT
WT
WT
Δcpa

Rotation in whole
human blood (3 h)
0.698
0.668
0.682
0.620
1.341
0.976

Rotation in human
plasma (3 h)a
ND
0.898
ND
1.013
0.906
ND

Table S5 in the supplemental material. ND, not determined.
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FIG 5 Meta-analysis of GAS survival in whole blood following emm deletion. The mean average %
survival relative to that of the wild type is shown for several Δemm mutants of different M types, based
on the ﬁndings of several other investigators (20–24). Each study used whole human blood and
logarithmic-phase GAS rotated for 3 h at 37°C, although inoculum doses may have differed slightly; the
% survival calculations were made in almost exactly the same way as that described for the Alab49
(emm53) strain from this report.

DISCUSSION
The classical skin strains of GAS differ from classical throat strains in both their
epidemiological associations and content of accessory genes (reviewed in reference 3).
The presence of fbaA among all cluster I impetigo isolates tested and its absence from
80% of cluster I pharyngitis isolates make FbaA a strong candidate for conferring tissue
speciﬁcity of infection at the skin for many cluster I organisms. The cluster I organisms
are deﬁned by their sharing of numerous other accessory genes (13), and therefore the
differential distribution of fbaA within cluster I may contribute to the throat versus skin
preference phenotypes. The humanized mouse model of impetigo provides support for
the hypothesis that FbaA enhances GAS ﬁtness at the skin, although the magnitude of
the effect is rather modest. Nonetheless, even a small ﬁtness advantage can contribute
to the shaping of larger epidemiological trends.
The humanized mouse model captures numerous pathogen-host interactions (reviewed in reference 11), including bacterial colonization and reproductive growth, the
latter of which may be constrained by the bacterium’s ability to acquire nutrients and
resist innate host defenses. The small but signiﬁcant contribution of FbaA to GAS
survival and growth in whole human blood may reﬂect an ability to resist opsonophagocytosis by extravasated mouse polymorphonuclear leukocytes during colonization of the superﬁcial epidermal layer in the hu-skin-SCID mouse model (17).
However, the antiphagocytic effect attributed to FbaA in Alab49 pales in comparison to
that of the M53 protein (i.e., PAM), which in turn is overshadowed by the collective
effect of Mga-regulated gene products.
Most studies measuring the contribution of M protein to blocking of phagocytosis
have employed emm pattern A-C and E strains, the so-called throat specialists and
generalists, respectively. With similarly designed bactericidal assays and calculations,
the % GAS survival in whole blood following emm gene deletion relative to that of the
WT was ⬍1% for pattern A-C strains of four different emm types (M1, M3, M5, and M6)
(20–22) (Fig. 5). For emm pattern E strains of M types 4 and 22, the survival of Δemm
mutants relative to that of the WT was 15.4 and 5.1%, respectively (23, 24). All values
are lower than the ⬃22% survival for Alab49Δpam (i.e., Alab49Δemm53) observed in
the present study (Fig. 5). Using slightly different calculations (i.e., using median values
in place of means), the survival of Δemm mutants relative to that of the WT is 2.0 and
17.7%, respectively, for pattern E strains of M types 2 and 49, respectively, and 18.2%
for an emm95 pattern D strain (previously known as 64/14 and renamed SS1343) (25).
Considering all reported values combined, the survival rates for Δemm mutants are
0.13% ⫾ 0.2%, 10% ⫾ 7.6%, and 20% ⫾ 2.5% for emm pattern groups A-C (throat
specialists), E (generalists), and D (skin specialists), respectively. This trend may be
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relevant to epidemiological ﬁndings showing that, of the three emm pattern groups,
pattern A-C strain emm types (followed by pattern E types) are most often associated
with invasive disease in each of six distinct global regions examined (26). The bactericidal assay with whole human blood may be a highly relevant experimental model for
invasive GAS disease (e.g., bacteremia).
Pandiripally et al. (27) reported the effects of M1 protein (and FbaA) on opsonophagocytosis of GAS in the bactericidal assay; however, precise % survival values
were not reported, so direct comparisons to the Alab49 data presented in Fig. 5 were
not attempted. By extrapolation of values from bar graphs, survival of the Δemm1
mutant appears to be (very) roughly 10% (27).
Studies of an FbaA variant derived from an M protein type 1 (M1) strain showed that
FbaA1 is a multifunctional cell surface protein that binds ﬁbronectin (Fn) and the
complement regulators factor H (FH) and factor H-like 1 (FHL-1) (28, 29). FHL-1 allows
GAS to resist opsonophagocytosis (27) and also facilitates epithelial cell invasion (28) in
an FbaA1-dependent manner. The overall amino acid sequence identity between
FbaA1 (MGAS5005) and FbaA53 (Alab49) is 88% following alignment using MUSCLE
(data not shown). FbaA from an invasive M type 53 GAS strain (AP53) displays 100%
amino acid sequence identity with FbaA53 from Alab49, and an AP53ΔfbaA mutant
exhibits reduced binding of FH (30). Although FH and FHL-1 binding to FbaA from
Alab49 (FbaA53) was not measured in this study, two regions of FH and FHL-1 binding
have been mapped for FbaA1 and can be compared as follows: the 16-amino-acid
sequence of region I has 87.5% identity to FbaA53, and the 18-amino-acid sequence of
region II is 100% identical to that of FbaA53 (28; data not shown). FbaA53 also has a
highly homologous COOH-terminal proline-rich repeat domain responsible for Fn
binding in its FbaA1 counterpart (31). Thus, it is expected, though not directly proven,
that FbaA53 from Alab49 also binds Fn and complement regulators and may function
in a manner similar to that of FbaA1. M1 strains are distinguished from many classic
throat strains in that they harbor an fbaA gene. Conceivably, the propensity of M1 GAS
to cause skin and soft tissue infections in temperate regions (26, 32) partially overlaps
the virulence strategy used by classic impetigo strains in causing superﬁcial skin
infections.
Both the M53 protein (i.e., PAM) and FbaA are positively regulated by Mga and
contribute to the virulence of strain Alab49 at the skin and to its survival in whole
blood. However, loss of Mga leads to a decrease in virulence, to well below the level of
the Alab49ΔfbaAΔpam double mutant. Additional Mga-regulated genes in the Alab49
strain include those that encode the surface proteins SclA (collagen-like) (9) and ScpA
(C5a peptidase) and the M-like proteins Mrp and Enn. After 3 h of rotation in whole
human blood, the number of surviving Alab49Δmga organisms was 8-fold lower than
that for the Alab49ΔfbaAΔpam double mutant, whereas 6 days after inoculation of the
human skin graft, the net growth of the Alab49ΔfbaAΔpam mutant exceeded that of
the Δmga mutant by almost 100-fold. Thus, another, unspeciﬁed Mga-regulated gene
product(s) makes a substantial contribution to the ﬁtness of the Alab49 strain under
pathological conditions. SclA, Mrp, and Enn are structurally diverse, and Mrp and Enn
are absent from most classical throat strains. Whether the functional features of these
surface proteins coordinate with the biological activities of PAM and FbaA to yield skin
tissue speciﬁcity of infection remains an open possibility, although any of the Mgaregulated genes—including many that remain unidentiﬁed in this study—may have a
contributory effect.
Other studies have reported that the GAS pilus alters the susceptibility of GAS to
phagocytosis in whole human blood by either increased bacterial killing (M1T1 strain;
FCT-2, emm pattern A-C) or decreased bacterial killing (M2T2 strain; FCT-6, emm pattern
E) (33, 34). The emm pattern D strain Alab49 expresses the FCT-3 form of pili (T serotype
T3/13/B) (7). In the present study, loss of pili in Alab49 due to mutation of the
transcriptional activator Nra gene or the pilus tip adhesion Cpa gene yielded nearly
equivalent levels of decreased survival in whole human blood; the decrease in survival
relative to that of Alab49WT was slight but signiﬁcant. The slight but signiﬁcant
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increase in survival following loss of MsmR parallels increased pilus production, although other MsmR-regulated genes may contribute to the effect.
The accessory gene content of classic skin strains (i.e., emm pattern D) is similar to
that of a highly prevalent subset of classic throat strains (i.e., cluster I, emm pattern A-C),
wherein the differential presence/absence of fbaA is tightly coupled to the two distinct
clinical phenotypes. Thus, gain/loss of fbaA may facilitate a transition in tissue site
preference for infection. Consistent with this hypothesis is the slight loss of ﬁtness at
the skin for the Alab49ΔfbaA mutant. Thus, FbaA and other emm pattern D-speciﬁc
gene products, such as PAM, and possibly Cpa (7) and/or the streptokinase lineage 2b
form (5, 12), may each contribute incrementally to shaping the phenotype for preferred
infection at the skin. The absence of any one of the impetigo-associated signature
genes may lead to a lower ﬁtness that reduces transmissibility ever so slightly and, over
time, that variant genotype may inch toward extinction from the global GAS population.
MATERIALS AND METHODS
Bacterial culture. GAS was cultivated in Todd-Hewitt broth supplemented with 1% yeast extract
(THYB). Mid-logarithmic-phase GAS cultures were grown to the optical density at 600 nm (OD600)
speciﬁed for each assay; stationary-phase cultures were cultures grown for 16 h. Escherichia coli used for
cloning and recombinant polypeptide expression was grown at 37°C in Luria broth (LB) with shaking. For
selection of GAS transformants harboring the antibiotic resistance genes aphA3 and aad9, kanamycin
was used at 500 g/ml and spectinomycin was used at 200 g/ml, respectively. GAS harboring pDCerm
was grown in the presence of 5 or 10 g/ml of erythromycin.
PCR-based screening. PCR products were generated using the primers listed in Table S1 in the
supplemental material. The genomic (gDNA) and plasmid DNAs used as templates were prepared as
previously described (7). Bacterial strains that underwent PCR-based screening included many from
previous reports (13, 35–37).
Bacterial mutants. Several targeted gene replacements were made in impetigo strain Alab49 (M
type 53). The fbaA gene was inactivated in both Alab49WT and an Alab49Δpam mutant (i.e., Δemm53)
(12) to generate the Alab49ΔfbaA single-gene mutant and the Alab49ΔfbaAΔpam double-gene mutant,
respectively (Fig. S1). Mutagenesis was achieved by allelic exchange following transformation of bacteria
with puriﬁed linear DNA containing the spectinomycin resistance gene (aad9) ﬂanked by sequences
upstream and downstream of the target gene, as previously described (7), using the oligonucleotide
primers listed in Table S1. The linear DNA cassette was generated using CloneAmp high-ﬁdelity
polymerase (Clontech, Mountain View, CA), and electroporation (2.5 kV, 200 ⍀, 25 F) (Micropulser
instrument; Bio-Rad, Hercules, CA) of glycine-grown competent GAS cells in 10% glycerol yielded a time
constant of ⬃5 to 6 ms, which is critical for yielding transformants in strain Alab49 by this method. Cells
underwent selection for antibiotic resistance, and the transformants were evaluated for replacement of
the target fbaA gene by PCR-based mapping and nucleotide sequence determination; growth curves for
the Alab49-derived mutants were identical (Fig. S2). Additional mutants used in this study, i.e.,
Alab49Δmga, Alab49Δnra, Alab49Δcpa, and Alab49ΔmsmR, were constructed and characterized as
previously described (7–10) (Fig. S1 and S3). Alab49Δmga::pMga667 is a transcomplemented strain with
pDCerm containing mga plus the 667-bp upstream autoregulatory region, as previously described (9);
Alab49Δmga::pEmpty is a transcomplemented strain with pDCerm lacking an insert. The Alab49ΔnraIG
mutant, lacking the nra gene plus the entire nra-cpa intergenic region (Fig. S3), was constructed by allelic
exchange with a linear DNA cassette containing the aphA3 gene (conferring kanamycin resistance) and
generated according to previously described methods (8), using the primers listed in Table S1. Controls
for caseinolytic digestion of mutant constructs are presented in Table S2.
Immunoﬂuorescence assay of bacterial cells. GAS cells were grown in THYB, with or without the
cysteine proteinase inhibitor E64 (25 M; Sigma-Aldrich, St. Louis, MO), for 24 h at 30°C. The 24-h cultures
were subsequently diluted 100-fold in fresh THYB, in the presence or absence of 25 M E64, and grown
at 30°C to either the mid-logarithmic or stationary phase, and cells were harvested by centrifugation and
washed in phosphate-buffered saline (PBS). To block nonspeciﬁc binding of immunoglobulins to Alab49
via cell surface IgG-binding proteins, GAS cells were suspended in a 1/10 volume of blocking solution
(PBS, pH 7.4, with 50 g/ml puriﬁed human IgG Fc fragment and 10% goat serum) and incubated at room
temperature for 1 h. Cell suspensions were subsequently split into equal volumes and centrifuged, and
bacterial pellets were suspended in preimmune or hyperimmune rabbit serum at a 1:1,000 dilution; these
mixtures were incubated at room temperature for 1 h and then washed with ice-cold PBS. Next, the
bacterial cells were stained with secondary antibody by incubation for 1 h with Alexa Fluor 488-labeled
goat anti-rabbit IgG F(ab=)2 (Life Technologies, Carlsbad, CA) at 1:250 in PBS and then were washed
thoroughly. Wet mounts were viewed on a Zeiss Axiovert 200 inverted motorized microscope with a
100⫻ oil immersion objective, and images were recorded using a Zeiss Axiocam MRm camera; ⱖ3 ﬁelds
per sample were visualized and recorded.
Hyperimmune rabbit serum. A recombinant polypeptide corresponding to the predicted mature
form of FbaA (rFbaA) of Alab49 was used to generate FbaA-speciﬁc antiserum. The fbaA gene of Alab49,
excluding the portions encoding the predicted signal peptide and the LPXTG motif and cell anchoring
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domain, was ampliﬁed by PCR from gDNA by use of LongAmp Taq polymerase and the oligonucleotide
primers listed in Table S1. The fbaA-derived PCR product was cloned into the E. coli plasmid expression
vector pGEX-3X (GE Healthcare Life Sciences, Pittsburgh, PA), and the recombinant plasmid was used to
transform Star BL21(DE3) competent E. coli cells. rFbaA was expressed as a fusion with an NH2-terminal
glutathione S-transferase (GST) tag, and rFbaA was afﬁnity puriﬁed using a GST SpinTrap column.
FbaA-speciﬁc antiserum was generated by intradermal injection of a rabbit (New Zealand White) with
400 g of puriﬁed rFbaA emulsiﬁed in TiterMax Gold adjuvant (Sigma-Aldrich, St. Louis, MO). Three
booster immunizations, each consisting of 400 g of rFbaA in TiterMax Gold, were administered at
4-week intervals; serum was collected 7 to 10 days after each immunization. All animal experimentation
was approved by the New York Medical College Institutional Animal Care and Use Committee.
RNA transcript levels. Total cellular RNAs were extracted from mid-logarithmic- and stationaryphase GAS cultures; cDNA was prepared from 1 g of puriﬁed RNA as previously described (8). For
qRT-PCR, oligonucleotide primers (Table S1) were designed to amplify a sequence of ⬃100 bp at the 5=
end of the target gene; samples in each qRT-PCR run were tested in triplicate. Expression of the target
gene was normalized to that of the housekeeping gene recA or to both recA and gyr, and relative RNA
transcript levels were measured using the 2⫺(ΔΔCT) method (8). Each gene was analyzed in ⱖ2 independent experiments, and the mean average fold change was calculated.
Casein digestion assay. For characterization of mutants, SpeB protease activity was measured on
Columbia agar plates (0.5⫻ Columbia agar [Sigma-Aldrich, St. Louis, MO], 1.5% Bacto agar, 3% skim milk
powder). Columbia agar was inoculated via stabs with single GAS colonies and incubated for 48 h at 37°C;
the diameter of the zone of clearance (i.e., casein digestion) around the inoculation site was measured
in millimeters. The cysteine protease inhibitor E64 (25 M in agar) and Alab49ΔspeB (7, 16) were included
as controls.
Impetigo model. A SCID mouse model engrafted with human skin (i.e., hu-skin-SCID mice) was used
in an experimental model of GAS impetigo (11, 17). For inoculation, a 0.002⫻ dilution of a midlogarithmic-phase (OD600, ⬃0.350) GAS culture grown at 37°C in 50 l of THYB was spotted onto
bandage pads and delivered to freshly scratched (nonbleeding) human skin grafts on the backs of
C.B-17-scid mice (Taconic Biosciences, Inc., Germantown, NY). In paired experiments, two skin grafts
present on a single mouse each received a bacterial inoculum at the same time; in unpaired experiments,
each skin graft was treated as an individual experiment. The number of CFU in each GAS inoculum was
calculated via serial dilutions on blood agar plates, performed in duplicate. Six days after inoculation with
GAS, human skin grafts were surgically removed, weighed, placed in sterile saline, and vigorously
vortexed to release the bacteria; the number of CFU associated with each biopsied skin graft was
calculated following (duplicate) serial dilutions of the released organisms. The number of bacterial
population doublings was calculated as the log2 of the ratio of the average mean CFU in skin biopsy
specimens to the average mean CFU in the inoculum. The relative bacterial growth index at the skin was
deﬁned as the ratio of the average mean CFU at 6 days postinoculation/inoculum CFU for the test strain
to the average mean CFU at 6 days postinoculation/inoculum CFU for the comparator strain.
Phagocytosis (bactericidal) assay. Growth of GAS in human whole blood was measured using a
modiﬁed version of the Lanceﬁeld bactericidal assay (12, 38). Heparinized human blood was kept on ice
and used for bactericidal assays within 2 h of collection; blood was collected in accordance with a
protocol approved by the New York Medical College Institutional Review Board for Human Subjects. For
the bactericidal assay, 400 l of heparinized blood was mixed with GAS (in 100 l THYB) and incubated
at 35°C for 3 h with rotation. GAS inoculums were based on dilutions of 1:8 and 1:2 of a 10,000-fold
dilution of early-logarithmic-phase cultures (OD600, ⬃0.150); actual inoculums (as determined by serial
dilution on blood agar plates, in duplicate, and CFU counts) ranged from ⬃50 to 200 CFU. Alab49WT and
its isogenic mutants were each tested with ⱖ2 different blood donors. GAS constructs were also tested
for the ability to grow in human plasma to rule out possible bacterial growth defects; plasma was
collected from the heparinized human blood samples by centrifugation. The number of bacterial
population doublings was calculated as the log2 of the ratio of the average mean CFU after 3 h of
incubation in whole blood or plasma to the average mean CFU in the inoculum. The relative bacterial
growth index was deﬁned as the ratio of the average mean CFU after 3 h of incubation in whole blood
(or plasma)/inoculum CFU for the test strain to the average mean CFU after 3 h of incubation in whole
blood (or plasma)/inoculum CFU for the comparator strain. The paired t test was performed for pairs of
organisms incubated in identical whole-blood or plasma samples.
Statistical analysis. Statistical signiﬁcance was measured using GraphPad for paired or unpaired
Student’s t test (two-tailed) and Fisher’s exact test (two-tailed). Correlation analysis was performed by
calculating Pearson’s correlation coefﬁcient.

SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/IAI
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